Vendor-Neutral Archive (VNA) and PACS Market Size and Outlook 2030

Report Description

Forecast Period	2026-2030
Market Size (2024)	USD 3.66 Billion
CAGR (2025-2030)	5.13%
Fastest Growing Segment	On-Site
Largest Market	North America
Market Size (2030)	USD 4.94 Billion

Market Overview

The Global Vendor-Neutral Archive (VNA) and PACS Market, valued at USD 3.66 Billion in 2024, is projected to experience a CAGR of 5.13% to reach USD 4.94 Billion by 2030. A Vendor-Neutral Archive (VNA) provides a centralized, standardized repository for medical images and associated clinical data, designed for seamless interoperability across diverse Picture Archiving and Communication Systems (PACS) and other healthcare information systems, ensuring long-term accessibility regardless of vendor. A PACS, conversely, is typically a departmental solution for managing medical images, often tied to a specific vendor's ecosystem, optimizing workflow within a particular clinical area like radiology.

The global VNA and PACS market growth is fundamentally driven by the escalating volumes of medical imaging data generated and the increasing imperative for robust interoperability and efficient image sharing across complex healthcare networks. Further momentum comes from the ongoing digitalization of healthcare records and the persistent regulatory emphasis on comprehensive electronic health record (EHR) implementation. A significant challenge impeding market expansion is the substantial initial investment and inherent complexities associated with integrating these advanced systems into existing legacy IT infrastructures. According to the HIMSS-SIIM Enterprise Imaging Community, as of December 2023, their collaborative white papers on enterprise imaging, which include VNA and PACS topics, collectively achieved over 100,000 accesses, indicating sustained industry engagement and relevance.

Key Market Drivers

The increasing volume of medical imaging data and the growing demand for healthcare interoperability and seamless data exchange represent the two most significant drivers for the Global Vendor-Neutral Archive (VNA) and PACS Market. The escalating number of diagnostic procedures, particularly advanced modalities, continuously expands the repository of images, necessitating robust management and archiving solutions. Traditional Picture Archiving and Communication Systems often face challenges with this scale, underscoring the vital role of VNAs in offering scalable, long-term storage and efficient retrieval. For example, according to Radiology Business, in May 2025, RadNet Inc. reported an 8.4% increase in MRI volume and an 8.4% increase in CT volume compared to the first quarter of 2024, highlighting the sustained growth in complex imaging studies.

Simultaneously, the demand for seamless information exchange across disparate healthcare platforms is crucial for delivering coordinated patient care and enhancing clinical outcomes. VNAs are instrumental in dismantling data silos, enabling standardized access and sharing of imaging data across the healthcare continuum, thereby improving diagnostic accuracy and treatment planning. According to an ONC report cited by Software Finder, in October 2024, approximately 70% of hospitals participated in all four domains of interoperable data exchange in 2023, reflecting the ongoing industry commitment to integrated data environments. This movement towards interconnected systems is supported by significant industry investments; according to Philips Statistics, in 2023, comparable sales of its Diagnosis and Treatment segment, which includes imaging, increased by 11%. This indicates a clear market response to the need for effective diagnostic information management.

Download Free Sample Report

Key Market Challenges

The substantial initial investment required for Vendor-Neutral Archive and Picture Archiving and Communication Systems, coupled with the inherent complexities of integrating these advanced solutions into existing legacy IT infrastructures, presents a notable impediment to market expansion. Healthcare organizations often face significant budgetary constraints, making the high upfront costs of VNA and PACS implementation a formidable barrier to adoption. This financial burden can delay or deter organizations from upgrading their imaging and data management systems, especially smaller institutions or those with limited capital expenditures.

Beyond the monetary outlay, the technical intricacies of migrating data and ensuring seamless interoperability between new VNA/PACS solutions and diverse legacy systems, which may include various departmental PACS and electronic health record platforms, necessitate extensive planning and specialized IT resources. This complexity can lead to prolonged deployment timelines and potential operational disruptions, further impacting the willingness of healthcare providers to initiate such transformative projects. According to a College of Healthcare Information Management Executives (CHIME) survey, in 2024, 67% of healthcare CIOs identified interoperability as a significant barrier to their digital transformation efforts. This indicates a pervasive concern that directly slows the modernization efforts essential for VNA and PACS market growth.

Key Market Trends

The growing integration of Artificial Intelligence in imaging workflows stands as a significant trend. This trend enhances the diagnostic capabilities and operational efficiency of VNA and PACS systems by automating tasks and providing intelligent analysis. At the Radiological Society of North America's (RSNA) 2024 annual meeting, 204 exhibitors showcased at least one AI product, underscoring the widespread industry focus on AI innovation. This adoption drives the market by enabling faster and more accurate diagnoses, reducing manual efforts, and ultimately improving patient outcomes. For example, GE HealthCare introduced new AI tools in May 2025 designed to support radiology workflows, aiming to make planning radiation for cancer treatment faster and more accurate.

The widespread adoption of cloud and hybrid cloud solutions represents another critical trend, transforming how VNA and PACS infrastructure is deployed and managed. These solutions offer enhanced scalability, accessibility, and cost-efficiency compared to traditional on-premise systems, addressing the ever-increasing volume of medical imaging data. According to the 2024 HIMSS State of Interoperability and Connected Care survey, nearly three fourths of healthcare systems lack access to medical images and unstructured patient information for informed decision-making, a challenge efficiently addressed by cloud architectures. This demand is leading major vendors to launch comprehensive cloud offerings, as evidenced by GE HealthCare announcing its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service solutions, at the 2025 HIMSS meeting.

Segmental Insights

The key segmental insight for the Global Vendor-Neutral Archive (VNA) and PACS Market indicates that while on-site deployments maintain a substantial market share, the cloud-based deployment model is currently experiencing the most rapid growth. This accelerated expansion stems from cloud solutions offering streamlined workflows, enhanced interoperability, and reduced infrastructure expenditures. Healthcare organizations are increasingly adopting cloud-based VNA and PACS to leverage scalable storage, robust disaster recovery capabilities, and advanced security protocols like encryption and granular access controls, essential for complying with regulations such as HIPAA. This trend supports efficient data exchange across diverse healthcare IT systems, promoting collaboration and remote diagnostics.

Regional Insights

North America leads the global Vendor-Neutral Archive (VNA) and PACS market, primarily due to its advanced healthcare infrastructure and high adoption of digital health solutions. This dominance is significantly driven by a robust regulatory landscape, including frameworks like the Health Insurance Portability and Accountability Act (HIPAA) and the Health Information Technology for Economic and Clinical Health (HITECH) Act, which mandate stringent data security, interoperability, and the adoption of electronic health records. These regulations encourage substantial investments in scalable image management solutions, facilitating efficient data sharing and supporting enterprise imaging strategies across diverse healthcare facilities.

Recent Developments

In April 2025, Siemens Healthineers and Tower Health entered into a 10-year strategic partnership. The collaboration focuses on upgrading imaging systems and digital tools across Tower Health facilities in Pennsylvania. This initiative is designed to enhance diagnostic capabilities and improve healthcare delivery through integrated imaging solutions. The partnership demonstrates a commitment to advancing enterprise imaging within the Global Vendor-Neutral Archive (VNA) and PACS Market by leveraging modern technology for improved patient outcomes.

In March 2024, GE HealthCare announced a new collaboration with Tribun Health focused on advancing Vendor Neutral Archive (VNA) capabilities. This partnership involves integrating VNA data directly into GE HealthCare's Edison VNA platform. The strategic initiative is designed to enhance interoperability across various medical imaging systems and provide clinicians with a more comprehensive and unified view of patient imaging data. This development aims to streamline workflows and improve data accessibility within the Global VNA and PACS Market.

In February 2024, FUJIFILM Healthcare Americas Corporation announced that its Synapse VNA and Synapse Radiology PACS solutions achieved the top ranking in the 2024 Best in KLAS Awards: Software and Services. This recognition, which highlights the company's capabilities, underscores its commitment to delivering high-performance software and service offerings. The award validates Fujifilm’s leadership in providing interoperable solutions that significantly improve patient care and support effective enterprise imaging strategies within the Global VNA and PACS Market.

In January 2024, RAMSoft launched OmegaAI, a comprehensive cloud-native, serverless imaging EMR software platform. This new product integrates several core functionalities essential for the Global Vendor-Neutral Archive (VNA) and PACS Market, including VNA, Enterprise Imaging, PACS, and RIS. The platform additionally offers streamlined image exchange, routing, storage, a zero-footprint viewer, unified worklist, and real-time business intelligence. OmegaAI aims to enhance radiology workflows and provide a holistic solution for medical image management.

Key Market Players

Agfa HealthCare NV
Dell Technologies Inc
FUJIFILM Holdings Corp
GE Healthcare Inc
International Business Machines Corp
Koninklijke Philips NV
Lexmark International Inc
McKesson Corp
Novarad Corp
Siemens Healthineers AG

By Imaging Modality	By Type	By Mode of Delivery	By Usage Model	By Region
Angiography Mammography Computed Tomography Magnetic Resonance Imaging Ultrasound Others	PACS VNA Software	On-Site Hybrid Cloud-hosted	Single Department Multiple Departments Multiple Sites	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Vendor-Neutral Archive (VNA) and PACS Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vendor-Neutral Archive (VNA) and PACS Market, By Imaging Modality:

o Angiography

o Mammography

o Computed Tomography

o Magnetic Resonance Imaging

o Ultrasound

o Others

Vendor-Neutral Archive (VNA) and PACS Market, By Type:

o PACS

o VNA Software

Vendor-Neutral Archive (VNA) and PACS Market, By Mode of Delivery:

o On-Site

o Hybrid

o Cloud-hosted

Vendor-Neutral Archive (VNA) and PACS Market, By Usage Model:

o Single Department

o Multiple Departments

o Multiple Sites

Vendor-Neutral Archive (VNA) and PACS Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ United Kingdom

§ Italy

§ Germany

§ Spain

o Asia Pacific

§ China

§ India

§ Japan

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Vendor-Neutral Archive (VNA) and PACS Market.

Available Customizations:

Global Vendor-Neutral Archive (VNA) and PACS Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Vendor-Neutral Archive (VNA) and PACS Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vendor-Neutral Archive (VNA) and PACS Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Imaging Modality (Angiography, Mammography, Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Others)

5.2.2. By Type (PACS, VNA Software)

5.2.3. By Mode of Delivery (On-Site, Hybrid, Cloud-hosted)

5.2.4. By Usage Model (Single Department, Multiple Departments, Multiple Sites)

5.2.5. By Region

5.2.6. By Company (2024)

5.3. Market Map

6. North America Vendor-Neutral Archive (VNA) and PACS Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Imaging Modality

6.2.2. By Type

6.2.3. By Mode of Delivery

6.2.4. By Usage Model

6.2.5. By Country

6.3. North America: Country Analysis

6.3.1. United States Vendor-Neutral Archive (VNA) and PACS Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Imaging Modality

6.3.1.2.2. By Type

6.3.1.2.3. By Mode of Delivery

6.3.1.2.4. By Usage Model

6.3.2. Canada Vendor-Neutral Archive (VNA) and PACS Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Imaging Modality

6.3.2.2.2. By Type

6.3.2.2.3. By Mode of Delivery

6.3.2.2.4. By Usage Model

6.3.3. Mexico Vendor-Neutral Archive (VNA) and PACS Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Imaging Modality

6.3.3.2.2. By Type

6.3.3.2.3. By Mode of Delivery

6.3.3.2.4. By Usage Model

7. Europe Vendor-Neutral Archive (VNA) and PACS Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Imaging Modality

7.2.2. By Type

7.2.3. By Mode of Delivery

7.2.4. By Usage Model

7.2.5. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Vendor-Neutral Archive (VNA) and PACS Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Imaging Modality

7.3.1.2.2. By Type

7.3.1.2.3. By Mode of Delivery

7.3.1.2.4. By Usage Model

7.3.2. France Vendor-Neutral Archive (VNA) and PACS Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Imaging Modality

7.3.2.2.2. By Type

7.3.2.2.3. By Mode of Delivery

7.3.2.2.4. By Usage Model

7.3.3. United Kingdom Vendor-Neutral Archive (VNA) and PACS Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Imaging Modality

7.3.3.2.2. By Type

7.3.3.2.3. By Mode of Delivery

7.3.3.2.4. By Usage Model

7.3.4. Italy Vendor-Neutral Archive (VNA) and PACS Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Imaging Modality

7.3.4.2.2. By Type

7.3.4.2.3. By Mode of Delivery

7.3.4.2.4. By Usage Model

7.3.5. Spain Vendor-Neutral Archive (VNA) and PACS Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Imaging Modality

7.3.5.2.2. By Type

7.3.5.2.3. By Mode of Delivery

7.3.5.2.4. By Usage Model

8. Asia Pacific Vendor-Neutral Archive (VNA) and PACS Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Imaging Modality

8.2.2. By Type

8.2.3. By Mode of Delivery

8.2.4. By Usage Model

8.2.5. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Vendor-Neutral Archive (VNA) and PACS Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Imaging Modality

8.3.1.2.2. By Type

8.3.1.2.3. By Mode of Delivery

8.3.1.2.4. By Usage Model

8.3.2. India Vendor-Neutral Archive (VNA) and PACS Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Imaging Modality

8.3.2.2.2. By Type

8.3.2.2.3. By Mode of Delivery

8.3.2.2.4. By Usage Model

8.3.3. Japan Vendor-Neutral Archive (VNA) and PACS Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Imaging Modality

8.3.3.2.2. By Type

8.3.3.2.3. By Mode of Delivery

8.3.3.2.4. By Usage Model

8.3.4. South Korea Vendor-Neutral Archive (VNA) and PACS Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Imaging Modality

8.3.4.2.2. By Type

8.3.4.2.3. By Mode of Delivery

8.3.4.2.4. By Usage Model

8.3.5. Australia Vendor-Neutral Archive (VNA) and PACS Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Imaging Modality

8.3.5.2.2. By Type

8.3.5.2.3. By Mode of Delivery

8.3.5.2.4. By Usage Model

9. Middle East & Africa Vendor-Neutral Archive (VNA) and PACS Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Imaging Modality

9.2.2. By Type

9.2.3. By Mode of Delivery

9.2.4. By Usage Model

9.2.5. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Vendor-Neutral Archive (VNA) and PACS Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Imaging Modality

9.3.1.2.2. By Type

9.3.1.2.3. By Mode of Delivery

9.3.1.2.4. By Usage Model

9.3.2. UAE Vendor-Neutral Archive (VNA) and PACS Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Imaging Modality

9.3.2.2.2. By Type

9.3.2.2.3. By Mode of Delivery

9.3.2.2.4. By Usage Model

9.3.3. South Africa Vendor-Neutral Archive (VNA) and PACS Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Imaging Modality

9.3.3.2.2. By Type

9.3.3.2.3. By Mode of Delivery

9.3.3.2.4. By Usage Model

10. South America Vendor-Neutral Archive (VNA) and PACS Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Imaging Modality

10.2.2. By Type

10.2.3. By Mode of Delivery

10.2.4. By Usage Model

10.2.5. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Vendor-Neutral Archive (VNA) and PACS Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Imaging Modality

10.3.1.2.2. By Type

10.3.1.2.3. By Mode of Delivery

10.3.1.2.4. By Usage Model

10.3.2. Colombia Vendor-Neutral Archive (VNA) and PACS Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Imaging Modality

10.3.2.2.2. By Type

10.3.2.2.3. By Mode of Delivery

10.3.2.2.4. By Usage Model

10.3.3. Argentina Vendor-Neutral Archive (VNA) and PACS Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Imaging Modality

10.3.3.2.2. By Type

10.3.3.2.3. By Mode of Delivery

10.3.3.2.4. By Usage Model

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Vendor-Neutral Archive (VNA) and PACS Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Agfa HealthCare NV

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Dell Technologies Inc

15.3. FUJIFILM Holdings Corp

15.4. GE Healthcare Inc

15.5. International Business Machines Corp

15.6. Koninklijke Philips NV

15.7. Lexmark International Inc

15.8. McKesson Corp

15.9. Novarad Corp

15.10. Siemens Healthineers AG

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Vendor-Neutral Archive (VNA) and PACS Market in 2024?

Which is the dominating region in the Global Vendor-Neutral Archive (VNA) and PACS Market?

Which is the fastest growing segment in the Global Vendor-Neutral Archive (VNA) and PACS Market?

What is the expected growth rate of the Global Vendor-Neutral Archive (VNA) and PACS Market?